Blood Cancer Treatment for International Patients in India

India is one of the most sought-after destinations for blood cancer treatment for international patients, offering chemotherapy, targeted therapy, immunotherapy, and bone marrow transplant at a fraction of the cost in Western countries. With internationally trained specialists, JCI-accredited hospitals, and end-to-end support for travel and visas, patients from Africa, the Middle East, and beyond receive world-class care with clear, personalised guidance from arrival to recovery.

Introduction

A blood cancer diagnosis can be very challenging, and when the treatment options in your home country feel limited, expensive, or confusing, the question of where to go next becomes urgent.

Every year, thousands of families from Africa, the Middle East, and South Asia travel to India and find the answer they were looking for, advanced therapies, trained specialists, hospitals that meet international standards and care that doesn’t drain a family’s entire savings.

Dr. Satyendra Katewa, Director of the Paediatric Haemato-Oncology and BMT Programme at Max Healthcare, Patparganj, Delhi, has treated over 10,000 young patients and completed more than 1,000 successful bone marrow transplants over 25 years of practice.  He works with families who have travelled from Nigeria, Kenya, Iraq, Bangladesh, and beyond, many of them carrying reports from multiple hospitals, looking for clarity and a plan they can trust.

This page walks you through everything you need to know about blood cancer care in India for overseas patients: what’s treated, how the journey works, what it costs, and what support is available when you arrive.

Why Do International Patients Choose India for Blood Cancer Treatment?

India offers internationally trained haematologists, advanced therapies including stem cell transplant and CAR T-cell therapy, and NABH/JCI-accredited hospitals at costs that are 60-80% lower than in the United States, United Kingdom, or the Gulf. Shorter waiting times and dedicated international patient support make the decision practical, not just affordable.

• A bone marrow transplant in India typically costs between USD 15,000 and USD 45,000, depending on the type of transplant and the patient’s condition. The same procedure in the United States can run anywhere from USD 100,000 to USD 200,000 or more, according to published cost data from Indian transplant centres.
• Patients can save between 60% and 80% without compromising on clinical standards.
• Beyond cost, India offers something that matters as much: experienced specialists who have treated hundreds of complex cases and hospitals that follow the same protocols used in the UK and the US.
• According to research published in The Lancet Regional Health Southeast Asia (2025), overall survival rates for children with acute lymphoblastic leukaemia at leading Indian centres using risk-stratified protocols reached 80-88%.
• Waiting time is another factor; in many countries, a bone marrow transplant or CAR T-cell therapy might mean a wait of several months. In Delhi, patients can often begin pre-treatment workup within days of arrival.
• For families coming from abroad, there is also a full ecosystem of support: visa assistance, airport pickup, accommodation, interpreter services, and a dedicated coordinator from the first email to the final follow-up.

What Types of Blood Cancer Are Treated?

Blood cancer is a broad term covering cancers that affect blood cells, bone marrow, and the lymphatic system. The three main categories are leukaemia, lymphoma, and multiple myeloma, and each has several subtypes that require different treatment approaches.

Leukaemia

• Leukaemia starts in the bone marrow and affects white blood cells.
• Dr. Katewa has particular expertise in paediatric leukaemia, including Acute Lymphoblastic Leukaemia (ALL), the most common childhood cancer, Acute Myeloid Leukaemia (AML), Chronic Myeloid Leukaemia (CML), and the rare Juvenile Myelomonocytic Leukaemia (JMML).
• According to the Cureus journal (2024), leukaemia accounts for 28% of all childhood cancer cases in India, reflecting both the scale of experience Indian specialists bring to the condition and the strength of local protocols.

Lymphoma

• Lymphoma affects the lymphatic system and is divided into Hodgkin lymphoma and Non-Hodgkin lymphoma.
• Both are treated with immunotherapy, chemotherapy, and in some cases, stem cell transplant. Hodgkin lymphoma in particular has very strong remission rates with current therapies.

Multiple myeloma

• Multiple Myeloma affects plasma cells in the bone marrow.
• Management is usually possible with targeted therapy, immunotherapy, and in selected patients, a stem cell transplant.

You can read more about blood cancer and related conditions on the conditions page to understand which subtype applies to your situation.

What Treatment Options Are Available in India for Blood Cancer?

In India, blood cancer treatment for international patients includes chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, and bone marrow transplant. The right combination depends on the type of blood cancer, the stage, and the patient’s age and overall health.

Here is what each approach involves:

Chemotherapy

• Chemotherapy uses powerful medicines to destroy cancer cells; it’s the backbone of most leukaemia and lymphoma treatment plans. Drugs are given in cycles, either by IV or orally, with recovery periods in between.
• According to the National Cancer Institute, approximately 98% of children with ALL attain initial remission on current chemotherapy regimens.

Targeted Therapy

• Targeted therapy uses medicines that focus on the specific protein or genetic mutation driving the cancer.
• This approach is especially effective in CML and certain subtypes of AML, it causes less damage to healthy cells compared to standard chemotherapy.

Immunotherapy

• Immunotherapy strengthens the body’s own immune system to recognise and attack cancer cells.
• This includes monoclonal antibodies and checkpoint inhibitors. It’s particularly useful for patients who haven’t responded fully to earlier treatment.

CAR T – Cell Therapy

• CAR T-cell therapy is one of the most advanced treatments now available in India. The patient’s own T-cells are modified in a lab and reinfused to directly attack cancer cells.
• India became one of the few countries to approve an indigenously developed CAR T therapy (NexCAR19) for the treatment of relapsed or refractory ALL and certain lymphomas. This brings a therapy that costs hundreds of thousands of dollars in the west within reach for international patients.

Stem Cell Transplant for Blood Cancer

• Stem cell transplant for blood cancer replaces diseased bone marrow with healthy stem cells from a matched donor or the patient’s own body.
• It’s used in high-risk or relapsed cases of leukaemia, lymphoma, and certain blood disorders. Dr. Katewa has completed over 1,000 such transplants, including haploidentical (half-matched) transplants for patients who don’t have a fully matched sibling donor.

How Does the Treatment Journey Work for International Patients?

The process for international patient blood cancer treatment in India follows a clear path: share your reports, receive an online medical review and treatment plan, apply for a medical visa using the hospital’s invitation letter, travel to India, begin treatment, and continue follow-up remotely after returning home. Most families complete the pre-arrival steps within one to two weeks.

Here is each step broken down:

Step 1: Share your medical reports: Send existing biopsy reports, blood test results, imaging (CT/MRI/PET scans), and any previous treatment records to the team.

Step 2: Receive a personalised treatment plan: The medical team reviews your case within 24-72 hours and sends a written treatment plan along with a cost estimate.

Step 3: Apply for a medical visa: India offers an e-Medical Visa, processed through the Indian government’s official e-Visa portal.

The e-Medical Visa is typically approved within 3-5 working days, is valid for 60 days, and allows up to three entries. Up to two family members can travel with you on Medical Attendant Visas.

Step 4: Travel and accommodation: The team coordinates airport pickup and can assist with accommodation close to the hospital, including options for the family members travelling with you.

Step 5: Arrive, register, and begin treatment: On arrival, patients are registered and assessed before treatment begins.

Step 6: Treatment and in-hospital recovery: Depending on the treatment type, hospital stays range from a few days per chemotherapy cycle to 3-6 weeks for a bone marrow transplant, with additional outpatient monitoring before the patient is cleared to fly home.

Step 7: Remote follow-up after returning home: Once back, patients stay connected through telemedicine consultations. Lab reports can be sent digitally, and the team advises on doctors for ongoing monitoring.

To get started, request a treatment plan or reach out directly through WhatsApp.

What Does Blood Cancer Treatment Cost in India for International Patients?

The cost of blood cancer treatment in India for foreign patients depends on the type of cancer, the stage, the treatment chosen, and the duration of stay. For instance, here are indicative cost ranges based on publicly available data from Indian hospitals:

These are indicative ranges only. A personalised cost estimate is provided after the medical team reviews your case.

For comparison:

An allogeneic bone marrow transplant in the United States typically costs USD 100,000-200,000. Research published in PMC confirms that transplant costs at leading Indian centres are significantly lower, with success rates that are nearly equivalent.

You can review bone marrow transplant cost details for a more specific breakdown.

Recovery Journey and Follow-Up Care After Returning Home

Recovery after blood cancer treatment usually depends mainly on the treatment approach followed.

• For chemotherapy, patients typically spend a few days in hospital per cycle and rest in between. For a bone marrow transplant, most patients stay in India for 6-10 weeks total, including the transplant period and early monitoring, before they are stable enough to fly.
• Before leaving India, Dr. Katewa’s team provides a full discharge summary with medication instructions, a schedule of tests to run at home, and guidance on which symptoms to watch for and act on immediately.
• Remote follow-up happens through scheduled telemedicine consultations, typically monthly in the first year after treatment and less frequently as results stabilise.
• Blood counts, imaging reports, and bone marrow assessments can be conducted locally and shared digitally with the team for review.
• For paediatric blood cancer treatment patients, the follow-up schedule is longer and more structured, as children require monitoring of growth, development, and organ function alongside cancer surveillance.
• Most families find that staying connected to their treating team in India gives them confidence during what can otherwise feel like an uncertain period.

Knowing there is a specialist who knows your case, who can read your report and respond within a day, makes the recovery at home feel much more manageable. If you have questions at any stage, contact our care team directly.

Take the First Step Towards Expert Care

You’ve read the information, you know the options exist, but somewhere in the back of your mind, the question remains: will this actually work for my child, my parent, my family?

That uncertainty is completely normal, but with an experienced team you don’t have to figure this out alone.

The Right Team Changes Everything 

Here is what happens when you reach out. Your reports go to a specialist who has seen this before, many times. Within 24-72 hours, you get a written treatment plan, not a vague response, but a specific recommendation with a cost estimate attached. No obligation. No pressure. Just clarity.

Book a consultation or reach out directly on WhatsApp at +91 8796133343. 

This information is for educational purposes only and should not be considered a substitute for professional medical advice.